Related references
Note: Only part of the references are listed.A statistical framework for determination of minimal plasmid copy number required for transgene expression in mammalian cells
Liangli Wang et al.
BIOELECTROCHEMISTRY (2021)
Non-Viral in Vitro Gene Delivery: It is Now Time to Set the Bar!
Nina Bono et al.
PHARMACEUTICS (2020)
Intratumoral Plasmid IL12 Electroporation Therapy in Patients with Advanced Melanoma Induces Systemic and Intratumoral T-cell Responses
Samantha K. Greaney et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Localized Interleukin-12 for Cancer Immunotherapy
Khue G. Nguyen et al.
FRONTIERS IN IMMUNOLOGY (2020)
A combination of electrochemotherapy, gene electrotransfer of plasmid encoding canine IL-12 and cytoreductive surgery in the treatment of canine oral malignant melanoma
Nina Milevoj et al.
RESEARCH IN VETERINARY SCIENCE (2019)
Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases
Julie Gehl et al.
ACTA ONCOLOGICA (2018)
Upregulation of DNA Sensors in B16.F10 Melanoma Spheroid Cells After Electrotransfer of pDNA
Katarina Znidar et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2018)
Electrotransfer of Different Control Plasmids Elicits Different Antitumor Effectiveness in B16.F10 Melanoma
Masa Bosnjak et al.
CANCERS (2018)
Clinically Usable Interleukin 12 Plasmid without an Antibiotic Resistance Gene: Functionality and Toxicity Study in Murine Melanoma Model
Urska Kamensek et al.
CANCERS (2018)
Efficacy and safety of electrochemotherapy combined with peritumoral IL-12 gene electrotransfer of canine mast cell tumours
M. Cemazar et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2017)
Plasmid DNA Manufacturing for Indirect and Direct Clinical Applications
Marco Schmeer et al.
HUMAN GENE THERAPY (2017)
Melanoma treatment with intratumoral electroporation of tavokinogene telseplasmid (pIL-12, tavokinogene telseplasmid)
David A. Canton et al.
IMMUNOTHERAPY (2017)
The promising alliance of anti-cancer electrochemotherapy with immunotherapy
Christophe Y. Calvet et al.
CANCER AND METASTASIS REVIEWS (2016)
Electrochemotherapy of tumors as in situ vaccination boosted by immunogene electrotransfer
Gregor Sersa et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Gene Electrotransfer of Canine Interleukin 12 into Canine Melanoma Cell Lines
Ursa Lampreht et al.
JOURNAL OF MEMBRANE BIOLOGY (2015)
Improved Specificity of Gene Electrotransfer to Skin Using pDNA Under the Control of Collagen Tissue-Specific Promoter
Spela Kos et al.
JOURNAL OF MEMBRANE BIOLOGY (2015)
Different Incubation Times of Cells After Gene Electrotransfer in Fetal Bovine Serum Affect Cell Viability, but Not Transfection Efficiency
Masa Bosnjak et al.
JOURNAL OF MEMBRANE BIOLOGY (2014)
Radiosensitizing effect of intratumoral interleukin-12 gene electrotransfer in murine sarcoma
Ales Sedlar et al.
BMC CANCER (2013)
Evaluation of p21 promoter for interleukin 12 radiation induced transcriptional targeting in a mouse tumor model
Urska Kamensek et al.
MOLECULAR CANCER (2013)
Interleukin-12 as a genetic adjuvant enhances hepatitis C virus NS3 DNA vaccine immunogenicity
Malihe Naderi et al.
VIROLOGICA SINICA (2013)
Electroporation driven delivery of both an IL-12 expressing plasmid and cisplatin synergizes to inhibit B16 melanoma tumor growth through an NK cell mediated tumor killing mechanism
Ha Kim et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
IL-12 DNA as molecular vaccine adjuvant increases the cytotoxic T cell responses and breadth of humoral immune responses in SIV DNA vaccinated macaques
Rashmi Jalah et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
Plasmid DNA Fermentation Strain and Process-Specific Effects on Vector Yield, Quality, and Transgene Expression
Aaron E. Carnes et al.
BIOTECHNOLOGY AND BIOENGINEERING (2011)
Irradiation, Cisplatin, and 5-Azacytidine Upregulate Cytomegalovirus Promoter in Tumors and Muscles: Implementation of Non-invasive Fluorescence Imaging
Urska Kamensek et al.
MOLECULAR IMAGING AND BIOLOGY (2011)
New Generation of Plasmid Backbones Devoid of Antibiotic Resistance Marker for Gene Therapy Trials
Gaelle Vandermeulen et al.
MOLECULAR THERAPY (2011)
Electrogene therapy with interleukin-12 in canine mast cell tumors
Darja Pavlin et al.
RADIOLOGY AND ONCOLOGY (2011)
Bleomycin/interleukin-12 electrochemogene therapy for treating naturally occurring spontaneous neoplasms in dogs
S. D. Reed et al.
CANCER GENE THERAPY (2010)
Cancer Electrogene Therapy with Interleukin-12
Maja Cemazar et al.
CURRENT GENE THERAPY (2010)
Preparation of pharmaceutical-grade plasmid DNA using methacrylate monolithic columns
Franc Smrekar et al.
VACCINE (2010)
Generic Plasmid DNA Production Platform Incorporating Low Metabolic Burden Seed-Stock and Fed-Batch Fermentation Processes
James A. Williams et al.
BIOTECHNOLOGY AND BIOENGINEERING (2009)
Controlled systemic release of interleukin-12 after gene electrotransfer to muscle for cancer gene therapy alone or in combination with ionizing radiation in murine sarcomas
Gregor Tevz et al.
JOURNAL OF GENE MEDICINE (2009)
p21(WAF1)-mediated transcriptional targeting of inducible nitric oxide synthase gene therapy sensitizes tumours to fractionated radiotherapy
H. O McCarthy et al.
GENE THERAPY (2007)
Standard operating procedures of the electrochemotherapy:: Instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the Cliniporator™ by means of invasive or non-invasive electrodes
Lluis M. Mir et al.
EJC SUPPLEMENTS (2006)
Electrochemotherapy -: An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases:: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study
Michel Marty et al.
EJC SUPPLEMENTS (2006)
Low-dose radiation response of the p21WAF1/CIP1 gene promoter transduced by adeno-associated virus vector
Mitsuru Nenoi et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2006)
Evaluation of toxicity following electrically mediated interleukin-12 gene delivery in a B16 mouse melanoma model
L Heller et al.
CLINICAL CANCER RESEARCH (2006)
Use of the radiation-inducible WAF1 promoter to drive iNOS gene therapy as a novel anti-cancer treatment
J Worthington et al.
JOURNAL OF GENE MEDICINE (2004)
Transcriptional targeting in cancer gene therapy
T Robson et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2003)
Electrochemo-gene therapy of cancer: Intratumoral delivery of interleukin-12 gene and bleomycin synergistically induced therapeutic immunity and suppressed subcutaneous and metastatic melanomas in mice
T Kishida et al.
MOLECULAR THERAPY (2003)
IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma
ML Lucas et al.
MOLECULAR THERAPY (2002)
Intradermal delivery of interleukin-12 plasmid DNA by in vivo electroporation
R Heller et al.
DNA AND CELL BIOLOGY (2001)
Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase
Z Chen et al.
VACCINE (2000)
Share Paper
